Suppr超能文献

补充锌对2019冠状病毒病(COVID-19)儿科患者症状减轻及住院时间的影响。

Effect of zinc supplementation on symptom reduction and length of hospital stay among pediatric patients with Coronavirus disease 2019 (COVID-19).

作者信息

Ibrahim Alhajjaji Ghufran, Alotaibi Nouf, Abutaleb Nada, Alotaibi Mishal M, Alhajjaji Abdulrahman, Alotaibi Abdulmalik S, Alshehail Bashayer, Alotaibi Moawad E

机构信息

Department of Pharmaceutical Care, Maternity and Children Hospital, Makkah, Saudi Arabia.

Umm Al-Qura university, Clinical pharmacy department, college of pharmacy, Makkah, Saudi Arabia.

出版信息

Saudi Pharm J. 2023 Apr;31(4):585-591. doi: 10.1016/j.jsps.2023.02.011. Epub 2023 Mar 4.

Abstract

OBJECTIVES

Zinc is considered an essential multipurpose trace element because of its ability to act as a cofactor and signaling molecule. As reported in earlier studies of pediatric respiratory infection management, zinc exhibits potent immunoregulatory and antiviral properties, but its effects on pediatric patients with COVID-19 remain unknown. The aim of this study was to determine the extent to which zinc supplementation improves COVID-19 symptoms, length of hospitalization and, to determine how zinc supplementation impacts ICU admission, in-hospital mortality, need for ventilation, duration of ventilation, need for vasopressors, development of liver injury, or respiratory failure.

METHODS

Pediatric patients younger than 18 years with confirmed COVID-19 infection during the study period (March 1, 2020, to December 31, 2021) were recruited for this retrospective cohort study. The study population was divided into two arms (zinc/no zinc supplementation as an adjunct to standard therapy).

RESULTS

Of 169 hospitalized patients who were screened, 101 met the inclusion criteria. No statistically significant association was found between the administration of zinc as adjunctive therapy and symptom reduction, intensive care unit (ICU) admission, or mortality (p = 0.105; p = 0.941, and p = 0.073, respectively). However, zinc supplementation was associated with a statistically significant reduction in respiratory failure and length of hospitalization (p = 0.004 and p = 0.017, respectively), also, zinc administration was associated with elevated serum creatinine (p = 0.01*).

CONCLUSIONS

Among pediatric patients with COVID-19, zinc supplementation was associated with shorter hospital stay. However, there was no significant difference between the two groups in terms of symptom improvement, in-hospital mortality, or ICU admission. In addition, the study raises question about the possibility of kidney injury as indicated by high levels of serum creatinine.

摘要

目的

锌被认为是一种必需的多功能微量元素,因为它能够作为辅助因子和信号分子发挥作用。正如早期儿科呼吸道感染管理研究中所报道的,锌具有强大的免疫调节和抗病毒特性,但其对新冠病毒病(COVID-19)儿科患者的影响仍不明确。本研究的目的是确定补充锌在多大程度上改善COVID-19症状、缩短住院时间,并确定补充锌如何影响入住重症监护病房(ICU)、院内死亡率、通气需求、通气持续时间、血管升压药需求、肝损伤发生或呼吸衰竭。

方法

本回顾性队列研究招募了在研究期间(2020年3月1日至2021年12月31日)确诊为COVID-19感染的18岁以下儿科患者。研究人群分为两组(补充锌/不补充锌作为标准治疗的辅助治疗)。

结果

在筛查的169例住院患者中,101例符合纳入标准。作为辅助治疗使用锌与症状减轻、入住重症监护病房(ICU)或死亡率之间未发现统计学上的显著关联(分别为p = 0.105;p = 0.941和p = 0.073)。然而,补充锌与呼吸衰竭和住院时间的统计学显著降低相关(分别为p = 0.004和p = 0.017),此外,使用锌与血清肌酐升高相关(p = 0.01*)。

结论

在COVID-19儿科患者中,补充锌与住院时间缩短相关。然而,两组在症状改善、院内死亡率或入住ICU方面没有显著差异。此外,该研究提出了关于血清肌酐水平升高所表明的肾损伤可能性的问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb2/10102417/d7d708e03495/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验